Form 4: WBA Director Acquires Phantom Stock Units

Walgreens Boots Alliance Director Robert Luther Huffines acquired 16,820.86 phantom stock units as part of his non-employee director compensation.

Summary

• Robert Luther Huffines, a Director of Walgreens Boots Alliance, Inc. (WBA), acquired phantom stock units.
• The transaction occurred on August 13, 2025.
• A total of 16,820.86 phantom stock units were acquired.
• Each phantom stock unit was valued at $11.89.
• Following this transaction, Robert Luther Huffines beneficially owns 46,813.12 phantom stock units.
• The phantom stock units were issued as an annual grant for non-employee director compensation under the Amended and Restated Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan.
• Each unit is the economic equivalent of one share of the company's common stock.
• The units include those issued in lieu of dividends on outstanding phantom stock units.
• The phantom stock units are to be settled following termination of service as a director.

Sentiment

Score: 7

Explanation: The filing reports a routine grant of phantom stock units to a director as part of their compensation, which is a neutral event but positively aligns the director's interests with shareholder value.

Positives

• Director compensation through phantom stock units aligns the director's financial interests with long-term shareholder value.
• The grant indicates continued commitment and retention of a key board member.

Risks

• The value of the phantom stock units is directly tied to the future performance of Walgreens Boots Alliance, Inc.'s common stock, exposing the holder to market fluctuations.
• Settlement of the units is deferred until termination of service, meaning the compensation is not immediately liquid.

Future Outlook

Phantom stock units are to be settled following termination of service as a director in accordance with the terms and conditions of the 2021 Omnibus Incentive Plan.

Industry Context

This filing reflects a standard compensation practice for non-employee directors in publicly traded companies, common across various industries, including retail pharmacy, to align director interests with long-term shareholder value.

Comparison to Industry Standards

• The grant of phantom stock units as non-employee director compensation is a common practice in large public companies like CVS Health (CVS) or Rite Aid (RAD), aligning director interests with long-term shareholder value.
• The specific value and number of units granted would typically be benchmarked against peer companies' director compensation structures to ensure competitiveness and fairness.

Corporate Governance

Related Party Transactions

• Acquisition of phantom stock units by Robert Luther Huffines, a director, as part of his compensation from Walgreens Boots Alliance, Inc.

Stakeholder Impact

• Shareholders: The director's interests are further aligned with shareholder value through phantom stock units tied to common stock performance.

Next Steps

• Settlement of phantom stock units will occur upon termination of service as a director.

Key Dates

Recommendation

This Form 4 filing details a routine compensation grant of phantom stock units to a director, which is a standard corporate governance practice. It does not provide new financial performance data or strategic shifts that would warrant a change in investment recommendation. The transaction aligns the director's interests with the company's long-term performance, which is generally positive, but it's not a catalyst for a 'buy' or 'sell' decision.

Keywords

Walgreens, WBA, Director, Phantom Stock, Compensation, SEC Form 4, Insider Transaction, Equity Compensation